Download presentation
Presentation is loading. Please wait.
1
Volume 4, Issue 2, Pages 192-195 (March 2018)
Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin Edwin Cuperus, MD, Rosanne Koevoets, MD, PhD, Jasper J. van der Smagt, MD, Johan Toonstra, MD, PhD, Marlies de Graaf, MD, PhD, Joost Frenkel, MD, PhD, Suzanne G.M.A. Pasmans, MD, PhD JAAD Case Reports Volume 4, Issue 2, Pages (March 2018) DOI: /j.jdcr Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 A, Erythroderma presented at age 7 weeks. B, DITRA with 6 months treatment with etanercept and acitretin, age 4 years and 3 months. JAAD Case Reports 2018 4, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
3
Fig 2 PASI scores of our patient during different treatments.
JAAD Case Reports 2018 4, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.